Prescriber's Corner
Ceritinib for ALK-Rearrangement–Positive Non–Small Cell Lung Cancer
Nancy M. Nix, PharmD, BCPS, BCOP, and Kaitlyn S. Brown, PharmD(c)
St. Joseph’s/Candler Health System–South Carolina Cancer Specialists, Hilton Head, South Carolina; University of Georgia College of Pharmacy, Athens, Georgia
Authors' disclosures of potential conflicts of interest are found at the end of this article.
Nancy M. Nix, PharmD, BCPS, BCOP, St. Joseph’s/Candler Health System–South Carolina Cancer Specialists, PO Box 21824, Hilton Head, SC 29925. E-mail: nixna@sjchs.org
J Adv Pract Oncol 2015;6:156–160 |
DOI: 10.6004/jadpro.2015.6.2.7 |
© 2015 Harborside Press®
For access to the full length article, please
sign in.
